Nascent Biotech Announces Successful Pritumumab In-Vitro Trial Data in Collaborative Covid-19 Treatment Study with Syracuse University
SAN DIEGO, CA / ACCESSWIRE / February 17, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) (“Nascent Biotech” or the “Company”), a clinical-stage biotech company pioneering the [...]